The development and validation of HPLC-DMD method for intermediate products impurities determination of morpholinium 2-((4-(2-methoxyphenyl)-5-(pyridine-4-yl)-4H-1,2,4-triazole-3-yl)thio)acetate in bulk drug

The development and validation of HPLC-DMD method for intermediate products impurities determination of morpholinium 2-((4-(2-methoxyphenyl)-5-(pyridine-4-yl)-4H-1,2,4-triazole-3-yl)thio)acetate in bulk drug

Purpose. A development and validation of new sensitive, high efficient and selective HPLC determination method of intermediates technological contaminations in bulk drug of morpholin-4-ium 2-((4-(2-methoxyphenyl)-5-(pyridine-4-yl)-4H-1,2,4-triazole-3-yl)thio)acetate (active pharmaceutical ingredient...

Full description

Bibliographic Details
Main Authors: B. O. Varynskyi, A. G. Kaplaushenko
Format: Article
Language:English
Published: Zaporozhye State Medical University 2017-06-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
triazoles
high pressure liquid chromatography
pharmaceutical products
drug contamination
Online Access:http://zmj.zsmu.edu.ua/article/view/100947/97449

Internet

http://zmj.zsmu.edu.ua/article/view/100947/97449

Similar Items